Replies to post #42334 on Ocata Therapeutics Inc fka OCAT

[lasers]

Naked Shorted Volume Mar 2012 data from FINRA up to Mar 26

http://regsho.finra.org/FORFshvol20120301.txt

Date Short Vol Total Vol % Short
Mar 2012

20120326 1075806 5889728 18
20120323 1,951,448 9,327,621 21
20120322 927,170 9,966,255 9
20120321 3,918,929 12,137,461 32
20120320 3,831,138 18,172,218 21
20120319 2,365,139 8,926,429 26
20120316 804,660 5,073,718 16
20120315 1,745,922 8,088,192 22
20120314 343,866 8,222,374 4
20120313 1,260,703 6,044,193 21
20120312 1,483,729 9,989,387 15
20120309 355,731 4,600,405 8
20120308 1,021,952 4,692,986 22
20120307 931,619 5,514,238 17
20120306 745,585 9,420,061 8
20120305 1,288,728 12,353,483 10
20120302 10,106,062 65,375,026 15
20120301 924,517 8,310,135 11

Mar 2012 35,082,704 212,103,910 17

Based on the 35 mil total as of Mar 26, expected annualized net profit with differential of $0.005 to $0.01 range between Naked Shorted PPS vs Covered Buy PPS exceeds $3 mil.

I am hoping also to post Jan 2012 and Feb 2012 data.

[Gastrodamas]

Right on.